Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2012-07-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne
NCT01629797
The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.
NCT07046039
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
NCT00494351
Efficacy of Handheld Acne Heat Device
NCT01613924
Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa
NCT06301256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A multidisciplinary team of trainers is involved. Primary endpoint is the general and skin dependent quality of life measured by questionnaires. HRQoL (Health-Related Quality of Life) is measured at baseline, after 3 months, 6 months and 9 months follow up. Patients are recruited from the out-patient clinic at the Department of Dermatology of the University Hospital Zurich. Patients are randomized in an intervention and control group. Intervention group receives the education program additionally to follow-up visits whereas the control group receives follow-up visits. Several runs are planned.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
patient group receiving regular follow-up visits (baseline, 3 months, 6 months, 9 months)
Control
Regular follow-up and treatment WITHOUT behavioural intervention
Haut Tief patient education
patient group receives the educational program with regular follow-up visits (baseline, 3 months, 6 months, 9 months).
Control
Regular follow-up and treatment WITHOUT behavioural intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control
Regular follow-up and treatment WITHOUT behavioural intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic eczema (disease for more than 3) months)
* Age ≥ 18 years
* Oral and written informed consent
Exclusion Criteria
* treatment with other investigational products
* other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc),
* known or suspected non-compliance, drug or alcohol abuse,
* inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia or confusional state of the subject
* participation in another study within the 30 days preceding and during the present study, (viii) previous enrollment into the current study,
* enrolment of the investigator, his/her family members, employees and other dependent persons.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guenther Hofbauer, Prof MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Dept. of Dermatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Department of Dermatology
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Haut-Tief
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.